Login
$ENRT
$0.06 +$0.02 (41.75%) Close

Consolidated interim balance sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of May 31, 2026
Q2 FY2026
As of Feb 28, 2026
Q1 FY2026
As of Nov 30, 2025
Q4 FY2025
As of Aug 31, 2025
Q3 FY2025
As of May 31, 2025
Q2 FY2025
As of Feb 28, 2025
Q1 FY2025
As of Nov 30, 2024
Q4 FY2024
As of Aug 31, 2024
Q3 FY2024
As of May 31, 2024
Q2 FY2024
As of Feb 29, 2024
Q1 FY2024
As of Nov 30, 2023
Q4 FY2023
As of Aug 31, 2023
Q3 FY2023
As of May 31, 2023
Q2 FY2023
As of Feb 28, 2023
Q1 FY2023
As of Nov 30, 2022
Q4 FY2022
As of Aug 31, 2022
Q3 FY2022
As of May 31, 2022
Q2 FY2022
As of Feb 28, 2022
Q1 FY2022
As of Nov 30, 2021
Q4 FY2021
As of Aug 31, 2021
ASSETS
Current
Cash and cash equivalents
Marketable securities
Cash
Accounts receivable
Prepaid expenses and deposit
Total Current Assets
Non-current assets, net
Mineral property
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' DEFICIT
LIABILITIES
Current
Accounts payable and accrued liabilities
Due to related party
Total Liabilities
STOCKHOLDERS' EQUITY
Authorized: 500,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 10,339,394 common shares at May 31, 2026 and August 31, 2025
Additional paid-in capital
Deficit
Equity attributable to shareholders of the Company
Non-controlling interest
Total Stockholders' Equity
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support